BogartLMOjikutuBOTyagiK, et al. COVID-19 related medical mistrust, health impacts, and potential vaccine hesitancy among black Americans living with HIV. J Acquir Immune Defic Syndr. 2021;86(2):200-207. doi:10.1097/QAI.0000000000002570.
2.
DrorAAEisenbachNTaiberS, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775-779. doi:10.1007/s10654-020-00671-y.
3.
WitbergGBardaNHossS, et al. Myocarditis after covid-19 vaccination in a large health care organization. N Engl J Med. 2021;385:2132-2139. doi:10.1056/NEJMoa2110737.
4.
MontgomeryJRyanMEnglerR, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 2021;6(10):1202-1206. doi:10.1001/jamacardio.2021.2833.
5.
BardaNDaganNBen-ShlomoY, et al. Safety of the BNT162b2 mRNA covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078-1090. doi:10.1056/NEJMoa2110475.
DanceaAB. Myocarditis in infants and children: a review for the paediatrician. Paediatr Child Health. 2001;6(8):543-545. doi:10.1093/pch/6.8.543.
8.
KlugmanDBergerJTSableCAHeJKhandelwalSGSlonimAD. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol. 2010;31(2):222-228. doi:10.1007/s00246-009-9589-9.
9.
MasonJWO’ConnellJBHerskowitzA, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333(5):269-275. doi:10.1056/NEJM199508033330501.
10.
ZambranoLDNewhamsMMOlsonSM, et al. Effectiveness of BNT162b2 (Pfizer—BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12—18 years—United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):52-58. doi:10.15585/mmwr.mm7102e1.
11.
RizkJGBarrCERizkYLewinJC. The next frontier in vaccine safety and VAERS: lessons from COVID-19 and ten recommendations for action. Vaccine. 2021;39(41):6017-6018. doi:10.1016/j.vaccine.2021.08.006.
Centers for Disease Control and Prevention. The vaccine adverse event reporting system (VAERS) request. Date unknown. Accessed October 20, 2021. https://wonder.cdc.gov/vaers.html.